Cargando…
The clinical utility of lurasidone in schizophrenia: patient considerations
Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the United Kingdom, other European countries, the United States, and Canada. In addition to full antagonist activity at the dopamine D(2) (Ki, 1 nM) and serotonin 5-HT(2A) (Ki, 0....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425313/ https://www.ncbi.nlm.nih.gov/pubmed/25995636 http://dx.doi.org/10.2147/NDT.S68417 |